Novo Nordisk A/S ADR buy Quitte
Start price
15.08.16
/
50%
€42.14
Target price
15.02.17
€44.65
Performance (%)
-26.05%
End price
15.02.17
€31.16
Summary
This prediction ended on 15.02.17 with a price of €31.16. The prediction for Novo Nordisk A/S ADR disappointed with a performance of -26.05%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novo Nordisk A/S ADR | 6.000% | 6.000% | -10.169% | 98.949% |
iShares Core DAX® | -0.258% | 0.299% | 15.648% | 15.944% |
iShares Nasdaq 100 | 2.964% | 4.660% | 32.001% | 57.194% |
iShares Nikkei 225® | 1.217% | -2.160% | 6.668% | 4.285% |
iShares S&P 500 | 1.732% | 2.807% | 25.596% | 48.530% |
Comments by Quitte for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
übertrieben
sooo schrecklich waren die Zahlen nicht
Analysten bleiben positiv
(Laufzeit überschritten)